Biopolymeric matrices for sustained release of plant-based biorepellents
Innovative biopolymeric matrices using natural microbial and plant-based polymers encapsulate essential oils for long-term biorepellent release. Ideal for fabrics and outdoor surfaces, this eco-friendly solution offers sustained insect repellent efficacy.
Overview
This solution introduces a novel approach to insect repellency through the use of biopolymeric matrices designed to encapsulate plant-based essential oils. Leveraging microbial biopolymers and plant-derived gummy exudates, these matrices form core/shell hydrogels that gradually release active volatile chemicals. This solution is particularly suited for outdoor applications, such as on fabrics and surfaces, providing a sustainable and environmentally friendly method for insect repellency with extended efficacy compared to traditional volatile repellents.
Technical specifications
The innovative system utilizes natural materials for encapsulation, including microbial biopolymers (levan) and mesquite gum from Prosopis nigra. Key technologies involved are complex coacervation and inverse gelation, which facilitate the creation of milli- and microcapsules. These capsules are engineered to regulate the diffusion of essential oils, ensuring a controlled and prolonged release of repellent agents. The process is designed to be simple, cost-effective, and scalable, making it suitable for commercial production. The formulation process considers various polymer proportions, emulsion stability, and encapsulation efficiency, with in vitro and outdoor testing planned to validate performance.
Technology readiness level
The development is at Technology Readiness Level 3, indicating experimental proof of concept has been achieved. The focus is now on refining production methods and conducting extensive testing to ensure reliability and efficacy in real-world settings.
About CITES (Sancor Seguros)
CITES (Centro de Innovación Tecnológica, Empresarial y Social) is a venture capital firm and venture builder focused on the development of deep tech and scientific-technological startups. Founded in 2013 and initially backed by the Sancor Seguros Group, the organization invests in companies from the formation stage through Series A, providing both capital and operational support. CITES operates with a multidisciplinary team and utilizes specialized infrastructure, including wet labs, fab labs, and co-working spaces, to assist founders in transforming disruptive scientific research into global businesses. Their portfolio spans various sectors such as biotechnology, agtech, artificial intelligence, med-tech, and sustainable industrial technologies.
By serving as a bridge between laboratory innovation and commercial application, CITES addresses the challenges of early-stage scientific entrepreneurship in Latin America. The firm is recognized for its role in fostering the regional deep tech ecosystem through investment funds and incubation programs designed to bridge the development gap for researchers and scientists. Through strategic partnerships and a commitment to social, environmental, and economic progress, CITES helps startups scale their solutions while promoting an inclusive and diverse innovation environment. Their operational model emphasizes applied knowledge, with a proven track record of managing numerous patents and building a diverse portfolio of companies focused on addressing modern global challenges.
delivered to your inbox.